Meeting abstract

EJACULATORY DYSFUNCTION IN PATIENT WITH SCHIZOPHRENIA ON SERTINDOLE

Marija Kušan Jukić ; Psychiatric Hospital Vrapče, Bolnička cesta 32, HR-10090 Zagreb, Croatia
Stipe Drmić ; Psychiatric Hospital „Sveti Ivan“, Zagreb, Croatia
Ninoslav Mimica ; School of Medicine, University of Zagreb, Šalata 3b, HR-10 000 Zagreb, Croatia

Abstract

The antipsychotic drugs can be of great benefit for the wide range of psychotic disorders, but all are associated with various
adverse effects. Patients with psychotic disorder consider the sexual dysfunction to be among the most important side effects.
Although, it is not uncommon for the patients with schizophrenia to report the sexual dysfunction, patients with untreated
schizophrenia have fewer dysfunctions compared to those on antipsychotic medication. The decision whether the current treatment
with a prolactin-increasing antipsychotic or sexual dysfunction inducing drug should be continued or switched to another
antipsychotic drug, has to be made on the basis of the patient's risk-benefit estimation. It has to be kept on mind that adverse effects
are usually dose dependent. In this case report, sertindole treated patient with chronic schizophrenia developed sexual side effect
manifested as ejaculatory dysfunction that was significantly ameliorated by drug-dose reduction.

Keywords

sexual dysfunction; schizophrenia; antipsychotics; sertindole

Hrčak ID:

48667

URI

https://hrcak.srce.hr/48667

Publication date:

10.2.2010.

Visits: 1.047 *